SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genencor (GCOR)- Recent IPO

 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Eric S. Lee who started this subject1/19/2001 9:39:56 PM
From: Hank   of 58
 
Allow me to be the first person to endorse GCOR. Biocatalysis is a hot topic for the pharmaceutical, chemical, and food industries and will become the norm, rather than the exception, in coming years. GCOR is positioned to capitalize on the sale of genetically engineered enzymes for use in industrial chemical synthesis and I expect to see double digit growth and new stock highs within 3-5 years.

You heard it here first folks.

The One and Only HANK!!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext